IN2012DN06416A - - Google Patents
Info
- Publication number
- IN2012DN06416A IN2012DN06416A IN6416DEN2012A IN2012DN06416A IN 2012DN06416 A IN2012DN06416 A IN 2012DN06416A IN 6416DEN2012 A IN6416DEN2012 A IN 6416DEN2012A IN 2012DN06416 A IN2012DN06416 A IN 2012DN06416A
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28893609P | 2009-12-22 | 2009-12-22 | |
US36174910P | 2010-07-06 | 2010-07-06 | |
PCT/US2010/061563 WO2011087790A1 (en) | 2009-12-22 | 2010-12-21 | Triple combination for lowering intraocular pres sure |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN06416A true IN2012DN06416A (es) | 2015-10-09 |
Family
ID=43743470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN6416DEN2012 IN2012DN06416A (es) | 2009-12-22 | 2012-07-20 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20130116254A1 (es) |
CN (1) | CN102695498A (es) |
AR (1) | AR079696A1 (es) |
BR (1) | BR112012017319A2 (es) |
CL (1) | CL2012001736A1 (es) |
CO (1) | CO6592061A2 (es) |
CR (1) | CR20120360A (es) |
EC (1) | ECSP12012033A (es) |
GT (1) | GT201200213A (es) |
IN (1) | IN2012DN06416A (es) |
MX (1) | MX2012007397A (es) |
NI (1) | NI201200112A (es) |
PE (2) | PE20160904A1 (es) |
TW (1) | TW201143773A (es) |
WO (1) | WO2011087790A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
TR201818754T4 (tr) | 2010-07-29 | 2019-01-21 | Allergan Inc | Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri |
EP2841104A1 (en) | 2012-04-24 | 2015-03-04 | Allergan, Inc. | Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use |
WO2016149498A1 (en) * | 2015-03-19 | 2016-09-22 | Allergan, Inc. | Fixed dose combination of bromonidine and timolol |
WO2019246130A1 (en) * | 2018-06-19 | 2019-12-26 | Cella Therapeutics, Llc | Sustained-release drug delivery systems comprising an intraocular pressure lowering agent, a cnp compound, an npr-b compound, a tie-2 agonist, or neurotrophic agent for use for treating glaucoma or ocular hypertension |
US12064440B2 (en) * | 2022-03-21 | 2024-08-20 | Somerset Therapeutics, Llc | Ophthalmic gel compositions of bimatoprost and timolol and associated methods |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5028624A (en) | 1989-07-27 | 1991-07-02 | Allergan, Inc. | Intraocular pressure reducing 9,15-diacyl prostaglandins |
US4994274A (en) | 1989-07-27 | 1991-02-19 | Allergan, Inc. | Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using |
US5034413A (en) | 1989-07-27 | 1991-07-23 | Allergan, Inc. | Intraocular pressure reducing 9,11-diacyl prostaglandins |
US7030149B2 (en) * | 2002-04-19 | 2006-04-18 | Allergan, Inc. | Combination of brimonidine timolol for topical ophthalmic use |
US7851504B2 (en) * | 2005-03-16 | 2010-12-14 | Allergan, Inc. | Enhanced bimatoprost ophthalmic solution |
-
2010
- 2010-12-21 BR BR112012017319A patent/BR112012017319A2/pt not_active Application Discontinuation
- 2010-12-21 CN CN2010800609772A patent/CN102695498A/zh active Pending
- 2010-12-21 PE PE2016000624A patent/PE20160904A1/es unknown
- 2010-12-21 PE PE2012000877A patent/PE20121468A1/es not_active Application Discontinuation
- 2010-12-21 US US13/698,182 patent/US20130116254A1/en not_active Abandoned
- 2010-12-21 WO PCT/US2010/061563 patent/WO2011087790A1/en active Application Filing
- 2010-12-21 MX MX2012007397A patent/MX2012007397A/es active IP Right Grant
- 2010-12-22 AR ARP100104881A patent/AR079696A1/es not_active Application Discontinuation
- 2010-12-22 TW TW099145385A patent/TW201143773A/zh unknown
-
2012
- 2012-06-22 GT GT201200213A patent/GT201200213A/es unknown
- 2012-06-22 NI NI201200112A patent/NI201200112A/es unknown
- 2012-06-22 CL CL2012001736A patent/CL2012001736A1/es unknown
- 2012-06-29 CR CR20120360A patent/CR20120360A/es unknown
- 2012-07-11 EC ECSP12012033 patent/ECSP12012033A/es unknown
- 2012-07-19 CO CO12122166A patent/CO6592061A2/es not_active Application Discontinuation
- 2012-07-20 IN IN6416DEN2012 patent/IN2012DN06416A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PE20160904A1 (es) | 2016-09-16 |
AR079696A1 (es) | 2012-02-15 |
CR20120360A (es) | 2012-07-30 |
PE20121468A1 (es) | 2012-10-28 |
CL2012001736A1 (es) | 2012-10-12 |
NI201200112A (es) | 2013-04-09 |
US20130116254A1 (en) | 2013-05-09 |
ECSP12012033A (es) | 2012-10-30 |
TW201143773A (en) | 2011-12-16 |
CO6592061A2 (es) | 2013-01-02 |
BR112012017319A2 (pt) | 2016-04-19 |
CN102695498A (zh) | 2012-09-26 |
GT201200213A (es) | 2014-08-29 |
WO2011087790A1 (en) | 2011-07-21 |
MX2012007397A (es) | 2012-08-15 |